Caffeine is consumed daily by approximately 80% of American adults, making it the most widely used psychoactive substance on the planet. The FDA considers up to 400 mg daily (roughly four 8-oz cups of brewed coffee) safe for healthy adults. Individual response varies dramatically: Dr. Ahmed El-Sohemy (University of Toronto) identified the CYP1A2 gene variant that divides the population into fast and slow metabolizers — slow metabolizers face elevated cardiovascular risk at the same doses that appear protective in fast metabolizers.
The benefits are well-documented. A 2024 BMJ umbrella review (k=201 meta-analyses, led by Dr. Robin Poole at the University of Southampton) confirmed that 3-5 cups of coffee daily is associated with a 25-30% reduction in type 2 diabetes risk, a 29% reduction in Parkinson disease, and significantly lower rates of liver cirrhosis and hepatocellular carcinoma. Decaffeinated coffee retains the metabolic and liver benefits, suggesting polyphenols and chlorogenic acids contribute independently of caffeine.
Sleep disruption is the most significant adverse effect. Caffeine has a half-life of 5-6 hours, but in CYP1A2 slow metabolizers it can extend to 9-11 hours. Dr. Matthew Walker (UC Berkeley) has noted that caffeine does not simply delay sleep onset — it reduces deep (N3) sleep by as much as 20%, degrading the restorative stages most people never notice missing.
Anxiety and caffeine form a dose-dependent relationship. Above 400 mg, anxiogenic effects become common. Dr. Uma Naidoo (Harvard, director of nutritional psychiatry at MGH) notes that genetic variants in the adenosine A2A receptor (ADORA2A) explain much of the individual variation — one person's morning focus is another person's panic trigger.
Pregnancy recommendations remain conservative: the ACOG recommends limiting intake to 200 mg daily. A 2020 BMJ Evidence-Based Medicine review by Dr. Jack James (Reykjavik University, 48 studies) found linear, dose-dependent associations between caffeine intake and both miscarriage (OR 1.32 per 150 mg/day) and low birth weight, with no safe threshold clearly identified.
The bottom line: moderate caffeine consumption (200-400 mg daily, consumed before noon) is safe and likely beneficial for most genetically typical adults. The exceptions: anxiety disorders, sleep difficulties, pregnancy, certain cardiac arrhythmias, and interactions with fluvoxamine, ciprofloxacin, and other CYP1A2 inhibitors that dramatically slow caffeine clearance.